Monitor whether the sale is executed and if other insiders follow with similar filings. The size is notable relative to recent insider selling patterns but small relative to market cap, so the immediate price impact is likely limited.
GKOS drugs
GKOS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Oct 30 $237.60entry
- T+1 · 15d ago +0.43%α +0.90% · $238.61
- T+5 · 11d ago −5.55%α −2.85% · $224.41
- T+11 · todayOpen
- T+20 · in 13d Pending
- T+60 · in 2mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Tomas Navratil, an officer of Glaukos Corp, filed a Form 144 notice of intent to sell 44,436 shares of common stock with an approximate market value of $10.6 million, based on the filing date price. The shares were acquired through restricted stock vesting and a stock option exercise, all from 2023 to 2026. The proposed sale represents a notable insider disposition relative to recent insider activity.
Key Facts
- Insider Tomas Navratil (Officer) filed Form 144 to sell 44,436 shares of Glaukos Corp common stock.
- Approximate market value of the proposed sale: $10,618,941.75.
- Shares were acquired through restricted stock vesting (various dates from 2023 to 2026) and a stock option exercise on 10/30/2026.
- The filing date is 2026-10-30; the proposed sale date is also 10/30/2026.
- Recent insider activity (30 days prior) showed 3 sells totaling $251K, making this proposed sale significantly larger.
- Glaukos Corp has a market cap of $10.7B, so the proposed sale represents about 0.1% of market cap.
Financial Impact
Proposed sale of 44,436 shares valued at approximately $10.6 million, representing about 0.1% of the company's $10.7B market cap.
Risk Factors
- Insider selling may signal lack of confidence or portfolio diversification; however, the shares were acquired through compensation, which is routine.
- The sale may not occur; Form 144 is only an intent to sell.
- No additional context from company filings or earnings is provided to assess timing relative to catalysts.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007569 |
| Document: 0001959173-26-007569-index.html | 0001959173-26-007569 |
| Document: 0001959173-26-007569.txt | 0001959173-26-007569 |
Track record
16 reports on GKOS
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $242.67 Now $244.88 +0.91% settles Nov 23
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $245.72 Now $244.88 −0.34% settles Nov 20
- Nov 6, 202610d ago 8-K Neutral 3/10 Entry $224.41 to $245.72 Now $244.88 +9.12% ▲ +9.50% +6.90% vs SPY
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $224.41 to $245.72 Now $244.88 +9.12% ▲ +9.50% +6.90% vs SPY
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $246.70 to $247.16 Now $244.88 −0.74% ▲ +0.19% +1.10% vs SPY
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $246.70 to $247.16 Now $244.88 −0.74% ▲ +0.19% +1.10% vs SPY
- Oct 30, 202617d ago 144 Neutral 3/10 Viewing Entry $237.60 to $224.41 Now $244.88 +3.06% ▼ −5.55% −2.85% vs SPY
- Oct 28, 202619d ago 8-K Bullish 6/10 Entry $242.48 to $219.98 Now $244.88 +0.99% ▼ −9.28% −4.55% vs SPY
- Aug 13, 202613w ago Insider Cluster Neutral 3/10 Entry $184.53 to $184.89 Now $244.88 +32.70% ▲ +0.20% +1.56% vs SPY
- Aug 11, 202613w ago Insider Cluster Neutral 2/10 Entry $186.63 to $189.55 Now $244.88 +31.21% ▲ +1.56% +2.01% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers